The minimum number of clones necessary to sequence in order to obtain the maximum information about hepatitis C virus quasispecies: A comparison of subjects with and without liver cancer

Journal of Viral Hepatitis

Volumn 12, Issue 1, 2005, Pages 46-50

  Gao, G ^a   Stuver, S O ^b,c   Okayama, A ^d   Tsubouchi, H ^d   Mueller, N E ^b   Tabor, Edward ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Hepatitis C virus; Hepatocellular carcinoma; Quasispecies

Indexed keywords

RNA DIRECTED RNA POLYMERASE;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC HETEROGENEITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CELL CARCINOMA; MOLECULAR CLONING; PRIORITY JOURNAL; SAMPLING; SEQUENCE HOMOLOGY; SPECIES DIFFERENTIATION; VIRUS GENOME;

HEPACIVIRUS; HUMANS; LIVER NEOPLASMS; VARIATION (GENETICS);

EID: 13244283306     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00546.x     Document Type: Article

References (11)

1. Okayama A, Stuver SO, Tabor E et al. Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat 2002; 9: 43-51.
2. Gao G, Buskell Z, Seeff L et al. Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients. J Med Virol 2002; 68: 60-67.
3. Choo Q-L, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451-2455.
4. Domingo E, Holland JJ. RNA virus mutations and fitness for survival. Annu Rev Microbiol 1997; 51: 151-178.
5. Korenaga M, Hino K, Katoh Y et al. A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization. J Viral Hepat 2001; 8: 331-340.
6. Koizumi K, Enomoto N, Kurosaki M et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 1995; 22: 30-35.
7. Torres-Puente M, Bracho MA, Jimenez N, Garcia-Robles I, Moya M, Gonzalez-Candelas F. Sampling and repeatability in the evaluation of hepatitis C virus genetic variability. J General Virol 2003; 84: 2343-2350.
8. Weiner AJ, Thaler MM, Crawford K et al. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol 1993; 67: 4365-4368.
9. Sugitani M, Shikata T. Comparison of amino acid sequences in hypervariable region-1 of hepatitis C virus clones between human inocula and the infected chimpanzee sera. Virus Res 1998; 56: 177-182.
10. Farci P, Bukh J, Purcell RH. The quasispecies of hepatitis C virus and the host immune response. Springer Semin Immunopathol 1997; 19: 5-26.
11. Duffy M, Salemi M, Sheehy M et al. Comparative rates of nucleotide sequence variation in the hypervariable region of E1/E2 and the NS5b region of hepatitis C virus in patients with a spectrum of liver disease resulting from a common source of infection. Virology 2002; 301: 354-364.